The US Food and Drug Administration (FDA) has announced a plan to phase out its animal testing requirement in developing monoclonal antibody therapies and other drugs with human-relevant alternatives. The Personal Care Products Council (PCPC) supports the proposal but urges the agency to expand the policy to include cosmetics and over-the-counter (OTC) personal care products, such as sunscreens.
